logo
The Big Squeeze: A behind-the-scenes look at reporting the decimation of Florida citrus

The Big Squeeze: A behind-the-scenes look at reporting the decimation of Florida citrus

Yahooa day ago
Florida once was the cornerstone of the most important meal of the day. How could breakfast be complete without a tall glass of orange juice? And more so, how could a tall glass of orange juice be complete without Florida oranges?
Today, however, Florida grows a mere fraction of the oranges it historically once did. TCPalm business reporter Jack Randall wanted to find out why. He spent months talking to experts, and analyzed more than a century's worth of citrus data.
I love orange juice (preferably without pulp), and ever since moving to the Treasure Coast, I've taken a liking to grapefruit, too.
The Treasure Coast is considered by many to grow the sweetest and juiciest grapefruit in the world.
But if you walk through Publix or any other grocery store, you'll more often than not find oranges and grapefruit from California or from another country. If Florida citrus is so great, why are Florida fruits so hard to come by?
I spoke with citrus industry professionals and academic researchers. They pointed to the same devastating root cause — citrus greening. It's a highly infectious disease that diminishes crop yields and ultimately kills citrus plants.
I combed through some of the first newspaper clippings and academic literature that reported on the bourgeoning agricultural epidemic. It first cropped up 20 years ago in South Florida. The disease — which is carried by an invasive insect — spread county-to-county, then nationwide.
I analyzed decades of data from the Florida Department of Agriculture and Consumer Services. I plotted the number of oranges and grapefruit grown in Florida over the past century. You'll notice a dip for 2004-2005.
During my research, a newspaper clipping caught my eye. It was one of the first media reports that contextualized the epidemic, with a tone that tried to remain optimistic.
'The apocalypse has not occurred," the Indian River Press Journal reported. "But the disease that results in bitter, misshapen fruit is said to be present in every grove to some extent.'
But that article was from 2013. What about now, 20 years after citrus greening was first reported? How much citrus is grown in modern Florida? The answer is staggering — and a lot less than what I imagined.
It's not all doom and gloom in the Sunshine State. Gene editing technology already has demonstrated promising results of fruit resisting citrus diseases.
Florida grapefruit may one day be cultivated using CRISPR gene-splicing technology at the DNA level.
Jack Randall is TCPalm's economy and real estate reporter. You can reach him at jack.randall@tcpalm.com or 904-466-4755.
This article originally appeared on Treasure Coast Newspapers: The Big Squeeze: A behind-the-scenes look at Florida's citrus decline
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

Yahoo

time35 minutes ago

  • Yahoo

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the 'Company'), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that Aquablation therapy was assigned a Category I code effective January 1, 2026. The 2026 Medicare Proposed Physician Fee Schedule (PFS) includes payment rates for a new Category I Current Procedural Terminology (CPT) code related to Aquablation therapy. Category I CPT code 52XX1 will replace Category III CPT code 0421T as the primary code for Aquablation therapy. 'Securing a Category I CPT Code marks a major milestone for PROCEPT, the urology community, and the patients we serve,' said Sham Shiblaq, chief commercial officer of PROCEPT BioRobotics. 'This transition recognizes the clinical value and widespread use of Aquablation therapy as we continue to make progress toward becoming the BPH surgical standard of care. The Category I code will further support surgeon adoption and broaden patient access to a treatment that delivers durable symptom relief with a low risk of sexual side effects.' The new CPT Category I Code 52XX1 was assigned a 2026 national Medicare physician proposed payment of 16.14 total RVUs which translates to an approximate national average of $540, under the 2026 proposed Medicare PFS. By comparison, TURP was assigned 15.82 total RVUs which translate to an approximate national average of $529. The PFS Proposed Rule was released on July 14, 2025, and updated payment policies and payment rates for services will be provided for Medicare beneficiaries on or after January 1, 2026. The Proposed Rule release is followed by a public comment period that will close in September 2025 and will culminate in CMS' release of the Final Rule, which is expected to be announced in November 2025 for implementation on January 1, 2026. The Proposed Rule is therefore subject to change. These 2026 proposed rule payment values and RVU assignments can be viewed on the CMS website at: About Aquablation TherapyAquablation therapy is the first and only ultrasound guided, robotic-assisted, heat-free waterjet for the treatment of BPH. The system's real-time ultrasound imaging provides the surgeon with a multi-dimensional view of the prostate enabling personalized treatment planning tailored to each patient's unique anatomy. The surgeon can specify which areas of the prostate to remove while preserving the anatomy that controls erectile function, ejaculatory function and continence. Once the treatment plan is mapped by the surgeon, the predictable robotic-assisted execution enables prostate tissue to be removed in a precise, targeted and controlled fashion. About PROCEPT BioRobotics CorporationPROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS™ Robotic Systems. The HYDROS Robotic System is the only AI-powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy. Forward-Looking StatementsThis press release may contain forward-looking statements within the meaning of federal securities laws. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from those anticipated or implied in such statements. PROCEPT BioRobotics undertakes no obligation to publicly update or revise any forward-looking statements. Important Safety InformationAll surgical treatments have inherent and associated side effects. For a list of potential side effects visit Investor Contact:Matt BacsoVP, Investor Relations and Business in to access your portfolio

Florida abortion numbers plummet in 2025 amid six-week ban
Florida abortion numbers plummet in 2025 amid six-week ban

CBS News

time43 minutes ago

  • CBS News

Florida abortion numbers plummet in 2025 amid six-week ban

The number of abortions reported in Florida during the first half of 2025 dropped 40.4 percent from the same period in 2024, amid a ban on most abortions after six weeks of pregnancy, according to new state data. A report posted online by the Florida Agency for Health Care Administration showed that 21,572 abortions had been reported this year as of July 1, down from 36,221 at the same point in 2024. Decreases were reported across Florida and among out-of-state residents, whose total dropped from 2,928 during the first six months of 2024 to 744 this year. Impact of six-week ban and trimester breakdown The law banning most abortions after six weeks of pregnancy took effect May 1, 2024, after a Florida Supreme Court ruling. The new data showed that 21,434 of the reported abortions this year occurred in the first trimester of pregnancies, while 138 were in the second trimester and none were in the third trimester. The largest number of second-trimester abortions, 87, were "performed due to fatal fetal abnormality," according to the Agency for Health Care Administration.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store